VENLAFAXINE BESYLATE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Venlafaxine Besylate, and what generic alternatives are available?

Venlafaxine Besylate is a drug marketed by Almatica and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in VENLAFAXINE BESYLATE is venlafaxine besylate. There are seventy-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the venlafaxine besylate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Venlafaxine Besylate

A generic version of VENLAFAXINE BESYLATE was approved as venlafaxine besylate by ALMATICA on June 29^th, 2022.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for VENLAFAXINE BESYLATE?
What are the global sales for VENLAFAXINE BESYLATE?
What is Average Wholesale Price for VENLAFAXINE BESYLATE?

Summary for VENLAFAXINE BESYLATE

US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	3
Clinical Trials:	1
Patent Applications:	9
DailyMed Link:	VENLAFAXINE BESYLATE at DailyMed

Drug patent expirations by year for VENLAFAXINE BESYLATE

Recent Clinical Trials for VENLAFAXINE BESYLATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Haining Health-Coming Biotech Co., Ltd.	Phase 2
Alphacait, LLC	Phase 2

See all VENLAFAXINE BESYLATE clinical trials

Pharmacology for VENLAFAXINE BESYLATE

Drug Class	Serotonin and Norepinephrine Reuptake Inhibitor
Mechanism of Action	Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for VENLAFAXINE BESYLATE

N06AX	Other antidepressants
N06A	ANTIDEPRESSANTS
N06	PSYCHOANALEPTICS
N	Nervous system

US Patents and Regulatory Information for VENLAFAXINE BESYLATE

VENLAFAXINE BESYLATE is protected by one US patents.

Patents protecting VENLAFAXINE BESYLATE

Extended release venlafaxine besylate tablets
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Almatica	VENLAFAXINE BESYLATE	venlafaxine besylate	TABLET, EXTENDED RELEASE;ORAL	215429-001	Jun 29, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for VENLAFAXINE BESYLATE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Almatica	VENLAFAXINE BESYLATE	venlafaxine besylate	TABLET, EXTENDED RELEASE;ORAL	215429-001	Jun 29, 2022	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Premature patent expiration for: VENLAFAXINE BESYLATE

Expiration due to failure to pay maintenance fee

Patent Number	Tradename	Expiration Date
⤷ Sign Up	VENLAFAXINE BESYLATE	⤷ Sign Up

International Patents for VENLAFAXINE BESYLATE

See the table below for patents covering VENLAFAXINE BESYLATE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
South Africa	200406461	Venlafaxine besylate	⤷ Sign Up
World Intellectual Property Organization (WIPO)	03082804		⤷ Sign Up
Australia	2003221535	VENLAFAXINE BESYLATE	⤷ Sign Up
European Patent Office	1485344	BESYLATE DE VENLAFAXINE (VENLAFAXINE BESYLATE)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration